BOK Financial’s GSK GSK Stock Holding History

BOK Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,389	Closed	-$400K	–	1427
2024 Q2	$400K	Buy	10,389 +1,787	+21%	+$75.2K	0.01%	642
2024 Q1	$365K	Sell	8,602 -1,141	-12%	-$47.1K	0.01%	611
2023 Q4	$361K	Sell	9,743 -265	-3%	-$9.51K	0.01%	589
2023 Q3	$357K	Sell	10,008 -2,510	-20%	-$89.1K	0.01%	579
2023 Q2	$446K	Sell	12,518 -619	-5%	-$22.2K	0.01%	564
2023 Q1	$467K	Sell	13,137 -6,765	-34%	-$237K	0.01%	574
2022 Q4	$699K	Sell	19,902 -8,412	-30%	-$280K	0.01%	602
2022 Q3	$834K	Sell	28,314 -4,684	-14%	-$178K	0.02%	542
2022 Q2	$1.8M	Buy	32,998 +465	+1%	+$25.7K	0.03%	390
2022 Q1	$1.77M	Sell	32,533 -653	-2%	-$35.5K	0.03%	437
2021 Q4	$1.83M	Buy	33,186 +176	+0.5%	+$9.15K	0.03%	437
2021 Q3	$1.58M	Buy	+33,010	New	+$1.66M	0.03%	455
2021 Q1	$3.59M	Buy	80,471 +51	+0.1%	+$2.31K	0.07%	280
2020 Q4	$3.7M	Buy	80,420 +2,096	+3%	+$96.3K	0.07%	258
2020 Q3	$3.69M	Buy	78,324 +4,837	+7%	+$242K	0.08%	223
2020 Q2	$3.75M	Buy	73,487 +14,036	+24%	+$720K	0.09%	216
2020 Q1	$2.82M	Buy	59,451 +8,284	+16%	+$442K	0.08%	238
2019 Q4	$3M	Buy	51,167 +9,637	+23%	+$536K	0.07%	278
2019 Q3	$2.22M	Buy	41,530 +9,956	+32%	+$512K	0.05%	331
2019 Q2	$1.58M	Sell	31,574 -2,485	-7%	-$125K	0.04%	384
2019 Q1	$1.78M	Buy	34,059 +964	+3%	+$48.2K	0.04%	372
2018 Q4	$1.58M	Buy	33,095 +1,252	+4%	+$61.7K	0.05%	360
2018 Q3	$1.6M	Sell	31,843 -1,823	-5%	-$92.6K	0.04%	412
2018 Q2	$1.7M	Sell	33,666 -1,369	-4%	-$69K	0.05%	385
2018 Q1	$1.71M	Sell	35,035 -16,563	-32%	-$771K	0.05%	379
2017 Q4	$2.29M	Sell	51,598 -22,516	-30%	-$1.04M	0.06%	324
2017 Q3	$3.76M	Buy	74,114 +7,428	+11%	+$377K	0.11%	214
2017 Q2	$3.6M	Buy	66,686 +4,769	+8%	+$254K	0.11%	206
2017 Q1	$3.26M	Buy	61,917 +1,803	+3%	+$91.5K	0.1%	224
2016 Q4	$2.89M	Sell	60,114 -7,772	-11%	-$384K	0.1%	234
2016 Q3	$3.66M	Sell	67,886 -1,036	-2%	-$56.8K	0.12%	194
2016 Q2	$3.73M	Sell	68,922 -2,924	-4%	-$154K	0.13%	168
2016 Q1	$3.64M	Buy	71,846 +1,176	+2%	+$58.6K	0.13%	182
2015 Q4	$3.56M	Buy	70,670 +1,464	+2%	+$74.6K	0.13%	192
2015 Q3	$3.33M	Sell	69,206 -35	-0.1%	-$1.82K	0.13%	193
2015 Q2	$3.6M	Buy	69,241 +2,043	+3%	+$115K	0.12%	196
2015 Q1	$3.88M	Buy	67,198 +11,393	+20%	+$653K	0.13%	185
2014 Q4	$2.98M	Sell	55,805 -3,684	-6%	-$206K	0.1%	221
2014 Q3	$3.42M	Buy	59,489 +5,397	+10%	+$331K	0.11%	204
2014 Q2	$3.62M	Buy	54,092 +6,813	+14%	+$461K	0.12%	191
2014 Q1	$3.16M	Buy	47,279 +399	+0.9%	+$27K	0.1%	217
2013 Q4	$3.13M	Buy	46,880 +2,819	+6%	+$183K	0.1%	213
2013 Q3	$2.76M	Sell	44,061 -588	-1%	-$37.9K	0.1%	225
2013 Q2	$2.79M	Buy	+44,649	New	+$2.83M	0.11%	202

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BOK Financial's GSK Position: Q3 2024 in Review

BOK Financial sold out of GSK (GSK) in Q3 2024, closing a stake of 10,389 shares — an estimated $400K sold.

BOK Financial first reported a position in GSK in Q2 2013 and held it in 44 quarters. The position peaked at $3.88M in Q1 2015. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

BOK Financial reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
BOK Financial sold 10,389 GSK shares in Q3 2024, an estimated $400K.
BOK Financial first reported a position in GSK in Q2 2013 and held it in 44 quarters.
BOK Financial's GSK position peaked at $3.88M in Q1 2015.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on BOK Financial's 13F filing for Q3 2024, filed 14 Nov 2024.